Nanotropil novo (Phenotropil) 100mg 30 pills

Pharmacodynamics

A nootropic drug with a pronounced antiamnestic effect, promotes the consolidation of memory, facilitates the learning process, increases the resistance of brain tissue to toxic effects, and has an anticonvulsant effect.

It has a positive effect on metabolic processes, stimulates redox processes, increases the energy potential of the body by utilizing glucose. Increases the content of norepinephrine, dopamine and serotonin in the brain, does not affect the level of GABA, does not bind to GABA and GABA receptors, and does not significantly affect the spontaneous bioelectric activity of the brain.

It has no effect on respiration and the cardiovascular system, exhibits an unexpressed diuretic effect, and has anorexigenic activity when used as a course.

The stimulating effect is manifested in the ability to provide a moderately pronounced effect, manifested in relation to motor reactions, increasing physical performance, as well as weakening the severity of the hypnotic effect of ethanol and hexobarbital.

The psychostimulating effect predominates in the ideational sphere.

The adaptogenic effect is manifested in an increase in the body's resistance to stress under conditions of excessive mental and physical exertion, with fatigue, hypokinesia and immobilization, at low temperatures.

Against the background of taking the drug, an improvement in vision was noted, which manifests itself in an increase in acuity, brightness and visual fields.

Improves blood flow to the lower extremities.

Stimulates the production of antibodies in response to antigen administration, which indicates immunostimulating properties, but at the same time does not contribute to the development of immediate hypersensitivity and does not change the allergic inflammatory reaction of the skin caused by the introduction of a foreign protein.

With course use, drug dependence, tolerance, "withdrawal syndrome" do not develop.

The effect is manifested in a single dose, which is important when using the drug in extreme conditions.

Indications for use

• Diseases of the central nervous system of various origins, accompanied by a deterioration in intellectual and mnestic functions, a decrease in motor activity.
• Neurotic conditions, manifested by memory impairment.
• Violations of the learning process.
• Psychoorganic syndromes, manifested by intellectual-mnestic disorders.
• Convulsive states.
• Obesity (alimentary-constitutional genesis).
• Prevention of hypoxia, increasing resistance to stress, correction of the functional state of the body in extreme conditions of professional activity in order to prevent the development of fatigue and to increase mental and physical performance.
• Chronic alcoholism (in order to reduce intellectual and mnestic disorders).

Drug interactions

Phenylpiracetam can enhance the effect of drugs that stimulate the central nervous system, and nootropic drugs.

Phenylpiracetam exhibits a pronounced antagonism to the cataleptic effect of neuroleptics, and also weakens the severity of the hypnotic effect of ethanol and hexobarbital.

Dosage

Take immediately after meals. The dose and duration of treatment should be determined by your doctor. Doses vary depending on the patient's condition. The average single dose is 150 mg (100 to 250 mg); the average daily dose is 250 mg (from 200 to 300 mg). The maximum daily dose of Nanotropil® novo is 750 mg. It is recommended to take a daily dose of up to 100 mg once in the morning, and over 100 mg should be divided into 2 doses. The duration of treatment can vary from 2 weeks to 3 months, with an average of 30 days. If necessary, the course can be repeated after 1 month.

To increase efficiency - 100-200 mg once in the morning, for 2 weeks (for athletes - 3 days).

The recommended duration of drug therapy in patients with alimentary-constitutional obesity is 30-60 days at a dose of 100-200 mg 1 time per day (in the morning). It is not recommended to take the drug later than 15 hours.